CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −9,766 | 58,599 | ||
| 2026-09-01 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +41,669 | 604,161 | ||
| 2026-09-01 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −17,702 | $8.28 | $147K | 586,459 |
| 2026-09-01 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −41,669 | 83,338 | ||
| 2026-09-01 | Puri Raj K. Chief Regulatory Officer | Option exercise | +5,470 | 253,584 | ||
| 2026-09-01 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −2,508 | $8.28 | $21K | 251,076 |
| 2026-09-01 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −5,470 | 10,939 | ||
| 2026-09-01 | BILINSKY IGOR Chief Operating Officer | Option exercise | +8,789 | 142,709 | ||
| 2026-09-01 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −4,472 | $8.28 | $37K | 138,237 |
| 2026-09-01 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −8,789 | 17,580 | ||
| 2026-08-10 | Kirby Daniel Gordon Chief Commercial Officer | Option exercise | +10,001 | 156,947 | ||
| 2026-08-10 | Kirby Daniel Gordon Chief Commercial Officer | Shares withheld for taxes | −2,436 | $6.40 | $16K | 154,511 |
| 2026-08-10 | Kirby Daniel Gordon Chief Commercial Officer | Option exercise · Restricted Stock Units | −10,001 | 60,003 | ||
| 2026-08-06 | Roche Corleen M. Chief Financial Officer | Option exercise | +49,995 | 49,995 | ||
| 2026-08-06 | Roche Corleen M. Chief Financial Officer | Shares withheld for taxes | −21,238 | $6.21 | $132K | 28,757 |
| 2026-08-06 | Roche Corleen M. Chief Financial Officer | Option exercise · Restricted Stock Units | −49,995 | 100,005 | ||
| 2026-06-16 | WEISER MICHAEL Director | Grant or award · Deferred Restricted Stock Unit | +90,316 | 90,316 | ||
| 2026-06-16 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +180,632 | 180,632 | ||
| 2026-06-16 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +90,316 | 90,316 | ||
| 2026-06-16 | Maynard Ryan D Director | Grant or award · Deferred Restricted Stock Unit | +90,316 | 90,316 |
Page 2 of 14 · 280 trades